Correlation Between Phio Pharmaceuticals and 180 Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and 180 Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and 180 Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and 180 Life Sciences, you can compare the effects of market volatilities on Phio Pharmaceuticals and 180 Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of 180 Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and 180 Life.

Diversification Opportunities for Phio Pharmaceuticals and 180 Life

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Phio and 180 is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and 180 Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 180 Life Sciences and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with 180 Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 180 Life Sciences has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and 180 Life go up and down completely randomly.

Pair Corralation between Phio Pharmaceuticals and 180 Life

Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the 180 Life. But the stock apears to be less risky and, when comparing its historical volatility, Phio Pharmaceuticals Corp is 2.42 times less risky than 180 Life. The stock trades about -0.04 of its potential returns per unit of risk. The 180 Life Sciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,995  in 180 Life Sciences on September 12, 2024 and sell it today you would lose (1,778) from holding 180 Life Sciences or give up 89.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Phio Pharmaceuticals Corp  vs.  180 Life Sciences

 Performance 
       Timeline  
Phio Pharmaceuticals Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Phio Pharmaceuticals Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Phio Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.
180 Life Sciences 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in 180 Life Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, 180 Life reported solid returns over the last few months and may actually be approaching a breakup point.

Phio Pharmaceuticals and 180 Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phio Pharmaceuticals and 180 Life

The main advantage of trading using opposite Phio Pharmaceuticals and 180 Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, 180 Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 180 Life will offset losses from the drop in 180 Life's long position.
The idea behind Phio Pharmaceuticals Corp and 180 Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data